Results 151 to 160 of about 4,028 (164)

Evaluating H56:IC31 vaccine in tuberculosis recurrence prevention

The Lancet Infectious Diseases
Wenping, Gong, Jingli, Du
openaire   +2 more sources

People also looked at

Frontiers in Microbiology, 2018
JoAnne Flynn, Thomas J Scriba, Denise Kirschner   +2 more
exaly   +2 more sources

People also looked at

Frontiers in Immunology, 2020
Harald S. Hansen, Fernanda Endringer Pinto, Christian Janfelt   +2 more
exaly  

Hemodynamic effects of alprenolol (H56-28).

Archives internationales de pharmacodynamie et de therapie, 1971
J D, Proctor, F J, Allen, A J, Wasserman
openaire   +1 more source

Новая вакцина H56 способна бороться с латентной туберкулезной инфекцией

Materials and Methods, 2011
openaire   +1 more source

Conservation in gene encoding antigen Rv2660 and a high predicted population coverage of H56 multistage vaccine in South Africa

Infection, Genetics and Evolution, 2017
Zhenhua Yang, Yongqun He, Edison Ong
exaly  

American Journal of Respiratory and Critical Care Medicine

American Journal of Respiratory and Critical Care Medicine, 2019
Angelique Kany Kany Luabeya, Thomas J Scriba, Hennie Geldenhuys   +2 more
exaly  

H165, H56, and H69 Against Murine and Human TARSH C Terminal-Half Fragment

Hybridoma, 2007
openaire   +1 more source

People also looked at

Frontiers in Immunology, 2017
Natalie E Nieuwenhuizen, Stefan Kaufmann, Teresa Domaszewska   +2 more
exaly  

[The use of the beta-adrenergic blocking agent H56-28 in arrhythmias].

Archivos del Instituto de Cardiologia de Mexico, 1969
M, Cárdenas, C, Brenes, J A, Ruipérez, J A, Hermosillo   +3 more
openaire   +1 more source